Halophyte-based vegetal salt substitute for hypertension and obesity management
Introducing a halophyte-based salt substitute with potential health benefits for hypertension and obesity. This innovative product leverages the unique phytochemical properties of halophytes to provide a healthier alternative to traditional salt.
Overview
Halophyte plants, known for their salty taste, offer a unique opportunity to create a healthier salt substitute. Unlike traditional salt, halophytes contain a balanced mineral composition with lower sodium and additional potassium, which can contribute to lowering blood pressure and managing obesity. This project aims to develop a marketable halophyte-based salt product that not only enhances flavor but also provides significant health benefits, marking a shift towards more health-conscious food consumption.
Technical specifications
- Phytochemical composition: Halophytes contain essential minerals and bioactive compounds with recognized anti-hypertensive and anti-inflammatory properties.
- In vivo and in vitro studies: The project involves studying the antioxidant and anti-inflammatory activities of halophytes, using both laboratory-based and live model systems to assess their impact on inflammation, hypertension, and obesity.
- Product development: Successful extracts from halophytes will be integrated into a new food product designed to replace traditional salt, offering a similar taste profile but with enhanced health benefits.
Technology readiness level
This research is currently at TRL 4, indicating that the basic technological components have been validated in a laboratory setting. Further development and testing are planned to advance the technology towards a viable commercial product.
About Universidade de Lisboa
Universidade de Lisboa is a comprehensive public research university in Portugal’s capital, uniting multiple schools and institutes with broad disciplinary coverage. Industry engages through co-located labs, shared core facilities, and campuses linked to research parks and Lisbon’s startup ecosystem. Integration with the university hospital network enables clinical research and translation, while experimental farms and field stations provide real-world testbeds. Research is supported by competitive European and national funding, including the European Commission and Portugal’s Fundação para a Ciência e a Tecnologia (FCT). A dedicated technology transfer office and incubation programs assist with IP, licensing, and startup formation.
Inquire about this partnering listing
Industry applications
delivered to your inbox.